S100A2 and non-small cell lung carcinoma: Given the contradictory nature of our data, we therefore sought to further characterise S100A2 expression in an independent (from the microarray analysed) series of NSCLC patients, and to further investigate the role of S100A2 in early preneoplastic bronchial lesions.